| 22nd week of 2022 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20220168247 | TOPICAL COMPOSITIONS FOR PAIN RELIEF, MANUFACTURE AND USE | 2022-06-02 |
| 20220168248 | METHOD FOR TREATING MELANOMA | 2022-06-02 |
| 20220168249 | METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE | 2022-06-02 |
| 20220168250 | TRIPLE COMBINATION OF AN ERK1/2 INHIBITOR WITH A BRAF INHIBITOR AND AN EGFR INHIBITOR FOR USE IN THE TREATMENT OF BRAFv6ooE COLORECTAL CANCER | 2022-06-02 |
| 20220168251 | PROCESS FOR PRODUCTION OF A NANO-MICROEMULSION SYSTEM OF FERULIC | 2022-06-02 |
| 20220168252 | RETINOID DERIVATIVES WITH ANTITUMOR ACTIVITY | 2022-06-02 |
| 20220168253 | PRODUCTION PROMOTER OF TYPE I COLLAGEN OR ELASTIN | 2022-06-02 |
| 20220168254 | PARENTERAL NUTRITION FORMULATION WITH OPTIMIZED AMINO ACID AND GLUCOSE CONTENT | 2022-06-02 |
| 20220168255 | PHARMACEUTICAL COMPOSITION CONTAINING DIMETHYL FUMARATE FOR ADMINISTRATION AT A LOW DAILY DOSE | 2022-06-02 |
| 20220168256 | METHODS USING ADMINISTRATION OF MEDIUM CHAIN TRIGLYCERIDES (MCT) PRIOR TO A MEAL TO INCREASE KETONE PRODUCTION FROM THE MCTS | 2022-06-02 |
| 20220168257 | METHODS USING MEDIUM CHAIN TRIGLYCERIDES ADMINISTERED PRIOR TO A MEAL TO DECREASE POSTPRANDIAL GLUCOSE FROM THE MEAL | 2022-06-02 |
| 20220168258 | METHOD FOR TREATING FEMALE NON-SMOKERS WITH NON-SMALL CELL LUNG CANCER | 2022-06-02 |
| 20220168259 | CHEMICAL DERIVATIVES AND METHODS FOR SYNTHESIZING AND COMPOUNDING CHEMICAL DERIVATIVES RELATED TO CAPSAICIN PALMITATE AND CAPSAICIN PRODRUGS | 2022-06-02 |
| 20220168260 | Methods and Compositions to Treat and Diagnose Diseases or Pathologies Associated with Inflammation of the Sinuses and Nasal Cavity | 2022-06-02 |
| 20220168261 | COMPOUNDS AND METHODS FOR MANAGING CANCER THROUGH IMMUNE SYSTEM | 2022-06-02 |
| 20220168262 | AMPHIPHILIC PLATINUM (IV) PRODRUG AND CANCER TREATMENT PROCESS | 2022-06-02 |
| 20220168263 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS | 2022-06-02 |
| 20220168264 | TREATMENT OF CIRCADIAN RHYTHM DISORDERS | 2022-06-02 |
| 20220168265 | PHARMACEUTICAL COMPOSITION COMPRISING TETRAHYDROCANNABIVARIN FOR THE PREVENTION AND TREATMENT OF OVERWEIGHT | 2022-06-02 |
| 20220168266 | CANNABIDIOL PREPARATIONS AND ITS USES | 2022-06-02 |
| 20220168267 | METHODS OF TREATING AUTOIMMUNE MICROVASCULAR DISORDERS | 2022-06-02 |
| 20220168268 | SMALL-MOLECULE INHIBITOR OF PD-1/PD-L1, PHARMACEUTICAL COMPOSITION THEREOF WITH PD-L1 ANTIBODY, AND APPLICATION OF SAME | 2022-06-02 |
| 20220168269 | METHODS OF TREATING DISORDERS ASSOCIATED WITH GLYCOSYLATION DEFECTIVE PROTEINS | 2022-06-02 |
| 20220168270 | COMPOSITIONS FOR PATHOGENESIS-DIRECTED THERAPY AND TREATMENTS OF SKIN DISEASES AND DISORDERS | 2022-06-02 |
| 20220168271 | COMPOSITIONS AND METHODS FOR INCREASING T CELL FUNCTION | 2022-06-02 |
| 20220168272 | PREPARATION OF SOLUBLE FORM OF CARVEDILOL | 2022-06-02 |
| 20220168273 | Pharmaceutical Combination for the Treatment of Cancer | 2022-06-02 |
| 20220168274 | Parenteral Formulation | 2022-06-02 |
| 20220168275 | THERAPEUTIC COMPOSITIONS COMPRISING DEUTERATED OR PARTIALLY DEUTERATED N,N-DIMETHYLTRYPTAMINE COMPOUNDS | 2022-06-02 |
| 20220168276 | Mehods and Compositions for Treating SARS-CoV-2 Infection using Carboxyamidotriazole Orotate | 2022-06-02 |
| 20220168277 | DRUG INHIBITOR AGAINST MIGRATION AND INVASION OF CANCER CELLS AND METHODS OF TREATING AGAINST METASTASIS OF CANCER CELLS | 2022-06-02 |
| 20220168278 | LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST | 2022-06-02 |
| 20220168279 | METHODS OF TREATING PAIN WITH A THIAZOLINE ANTI-HYPERALGESIC | 2022-06-02 |
| 20220168280 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | 2022-06-02 |
| 20220168281 | NK-1 ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN TREATING DEPRESSION | 2022-06-02 |
| 20220168282 | INHIBITION OF COVID-19 VIRUS | 2022-06-02 |
| 20220168283 | TREATMENT OF PROGRESSIVE NEURODEGENERATIVE DISEASE WITH IBUDILAST | 2022-06-02 |
| 20220168284 | PHOSPHOINOSITIDE 3-KINASE INHIBITOR WITH A ZINC BINDING MOIETY | 2022-06-02 |
| 20220168285 | PHARMACEUTICAL COMPOSITIONS | 2022-06-02 |
| 20220168286 | TREATMENT OF RAYNAUD'S DISEASE | 2022-06-02 |
| 20220168287 | Methods Of Treating Fabry Patients Having Renal Impairment | 2022-06-02 |
| 20220168288 | Methods Of Treating Fabry Patients Having Renal Impairment | 2022-06-02 |
| 20220168289 | Methods Of Treating Fabry Patients Having Renal Impairment | 2022-06-02 |
| 20220168290 | Methods Of Treating Fabry Patients Having Renal Impairment | 2022-06-02 |
| 20220168291 | Methods Of Treating Fabry Patients Having Renal Impairment | 2022-06-02 |
| 20220168292 | Methods Of Treating Fabry Patients Having Renal Impairment | 2022-06-02 |
| 20220168293 | TIME TO RESOLUTION OF AXITINIB-RELATED ADVERSE EVENTS | 2022-06-02 |
| 20220168294 | TREATMENT OF CNS CONDITIONS | 2022-06-02 |
| 20220168295 | RIMEGEPANT FOR CGRP RELATED DISORDERS | 2022-06-02 |
| 20220168296 | METHODS OF TREATING CANCER WITH FARNESYLTRANSFERASE INHIBITORS | 2022-06-02 |
| 20220168297 | METHODS AND COMPOSITIONS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ASTHMA, PNEUMONIA, BRONCHITIS, CYSTIC FIBROSIS, PULMONARY EDEMA, INTERSTITIAL LUNG DISEASE, SARCOIDOSIS, IDIOPATHIC PULMONARY FIBROSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND PULMONARY ARTERIAL HYPERTENSION | 2022-06-02 |
| 20220168298 | CANCER TREATMENT | 2022-06-02 |
| 20220168299 | PHARMACEUTICAL COMPOSITION COMPRISING TBN, OR SALT OR HYDRATE THEREOF, AND PREPARATION METHOD THEREOF | 2022-06-02 |
| 20220168300 | Methods of Managing Vascular Conditions and Diabetic Peripheral Neuropathies | 2022-06-02 |
| 20220168301 | METHODS FOR TREATING SYMPTOMATIC ORTHOSTATIC HYPOTENSION | 2022-06-02 |
| 20220168302 | SALTS OF A COMPOUND, CRYSTAL FORMS OF THE SALTS AND PREPARATION METHOD AND USE THEREOF | 2022-06-02 |
| 20220168303 | TREATMENT OF HER2 POSITIVE CANCERS | 2022-06-02 |
| 20220168304 | METHODS FOR TREATING CYSTIC FIBROSIS | 2022-06-02 |
| 20220168305 | Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations | 2022-06-02 |
| 20220168306 | Dosing Regimens Associated With Extended Release Paliperidone Injectable Formulations | 2022-06-02 |
| 20220168307 | TREATMENT OF SMA | 2022-06-02 |
| 20220168308 | METHODS FOR TREATING ALZHEIMER DISEASE AND FOR REDUCING AMYLOID BETA FORMATION | 2022-06-02 |
| 20220168309 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE | 2022-06-02 |
| 20220168310 | INHIBITION OF ADENOVIRUS WITH FILOCICLOVIR | 2022-06-02 |
| 20220168311 | THERAPEUTIC AGENT FOR PARKINSON'S DISEASE | 2022-06-02 |
| 20220168312 | MULTICOMPONENT CRYSTAL FORMULATIONS | 2022-06-02 |
| 20220168313 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | 2022-06-02 |
| 20220168314 | MEDICAMENT FOR PROPHYLAXIS OR TREATMENT OF PULMONARY FIBROSIS | 2022-06-02 |
| 20220168315 | COMPOUNDS AND THERAPEUTIC USES THEREOF | 2022-06-02 |
| 20220168316 | METHODS AND COMPOSITIONS FOR TREATING UREA CYCLE DISORDERS | 2022-06-02 |
| 20220168317 | Therapeutic Thiazine Dye Compositions and Methods of Use | 2022-06-02 |
| 20220168318 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF INSOMNIA | 2022-06-02 |
| 20220168319 | COMBINED USE OF A-NOR-5alpha ANDROSTANE COMPOUND DRUG AND ANTICANCER DRUG | 2022-06-02 |
| 20220168320 | HYALURONAN CONJUGATES WITH PHARMACEUTICALLY ACTIVE SUBSTANCES, METHODS AND COMPOSITIONS | 2022-06-02 |
| 20220168321 | PHARMACEUTICAL CARRIERS CAPABLE OF pH DEPENDENT RECONSTITUTION AND METHODS FOR MAKING AND USING SAME | 2022-06-02 |
| 20220168322 | NOVEL STAT3 INHIBITORS IDENTIFIED BY STRUCTURE-BASED VIRTUAL SCREENING INCORPORATING SH2 DOMAIN FLEXIBILITY | 2022-06-02 |
| 20220168323 | CONCENTRATED LIQUID PHARMACEUTICAL FORMULATIONS OF FUROSEMIDE | 2022-06-02 |
| 20220168324 | CANCER THERAPY | 2022-06-02 |
| 20220168325 | METHODS TO PROMOTE CEREBRAL BLOOD FLOW IN THE BRAIN | 2022-06-02 |
| 20220168326 | THERAPEUTIC COMBINATIONS COMPRISING ANTI-FOLR1 IMMUNOCONJUGATES | 2022-06-02 |
| 20220168327 | Compounds for Treating and Preventing Net Associated Complications | 2022-06-02 |
| 20220168328 | METHODS AND COMPOSITIONS FOR TREATING EUKARYOTIC INFECTIONS VIA ALTERING AGGREGATION DYNAMICS OF RAPTOR/KOG1 | 2022-06-02 |
| 20220168329 | COMBINATORIAL DRUG TREATMENT OF CANCER | 2022-06-02 |
| 20220168330 | ANTIBODY DRUG CONJUGATES | 2022-06-02 |
| 20220168331 | PRR-Activating and MicroRNA-Inhibiting Molecules and Methods of Using Same | 2022-06-02 |
| 20220168332 | Multiplex shRNA for Use in Vectors | 2022-06-02 |
| 20220168333 | Combination Treatment for Hematological Cancers | 2022-06-02 |
| 20220168334 | SYSTEM AND METHOD TO REDUCE TISSUE ORORGAN ADHESION | 2022-06-02 |
| 20220168335 | Hyaluronic Acid Derivatives for Wound Healing | 2022-06-02 |
| 20220168336 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | 2022-06-02 |
| 20220168337 | PRODUCING ATP AND IMPROVING MITOCHONDRIAL FUNCTION IN A MAMMAL USING A POLY-OXYGENATED METAL HYDROXIDE | 2022-06-02 |
| 20220168338 | PREVENTION OF INFECTION BY HIGHLY PATHOGENIC VIRUSES USING TOPICAL APPLICATION OF POVIDONE-IODINE ON MUCOUS MEMBRANES | 2022-06-02 |
| 20220168339 | Anti-Inflammatory Compositions and Methods | 2022-06-02 |
| 20220168340 | UTILIZING THE INNATE IMMUNE SYSTEM TO DELIVER THERAPEUTIC AGENTS | 2022-06-02 |
| 20220168341 | COMPOSITIONS AND METHODS OF TREATING DRY EYE SYNDROME AND OTHER TRAUMATIZED NON-KERATINIZED EPITHELIAL SURFACES | 2022-06-02 |
| 20220168342 | GENOME EDITED PRIMARY B CELL AND METHODS OF MAKING AND USING | 2022-06-02 |
| 20220168343 | CANCER IMMUNOTHERAPY USING COMBINATIONS OF CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND MONOCLONAL ANTIBODIES | 2022-06-02 |
| 20220168344 | COMPOSITIONS AND METHODS FOR TREATING CANCER WITH SELF-DRIVING CHIMERIC ANTIGEN RECEPTORS | 2022-06-02 |
| 20220168345 | T CELL RECEPTORS AND METHODS OF USE THEREOF | 2022-06-02 |
| 20220168346 | T CELL RECEPTORS AND METHODS OF USE THEREOF | 2022-06-02 |
